i think we get a runup into the om and t results. i am a little concerned about t being a wildcard. oral om, not so much. its gonna be fun.
getting through this 4.25 ish level is like watching paint dry. boring is good i guess, but its boring
Sentiment: Strong Buy
a compound that would make people quit smoking would be the blockbuster of all copd treatments
yea, that caught my eye as well. first thing i thought about was the poor saps that would end up with a placebo when they have md? then after a little more digging i read about the lucentis part.
lol, that is great. after reading that, my runup trade bells started going off. its got all the ingredients, major hype, newsletters, "blockbuster" drug, huge retail base, low float... and now a "leak" about how amazing the drug is! i can see the thing running to 12 bucks or more into next year.
truth is... every time yahoo "improves" the site, it gets worse
anyone figure out how to get to the boards on a smart phone yet?
yes, left-e, you hit the nail on the head here. i looked into OHRP a while back and came to the conclusion that if the drops worked... if... then they would become a maintenance treatment at best. we all know the potential of isonep, thats why we are investors in the company and have hug in with all the setbacks. good luck livermore
my math is the same as yours. this is so unclear... it appears that my BZNE trade is at an end i will probably sell today. we shall see how the market views this deal soon enough
so do we get stock then? the musclepharm pr is a little better, but still pretty confusing. anyone want to clear this up?
i think pfizer has them in a corner not with the partnership overall but, the way lpath has been told what to do. the denial of completing the ped trial and the asonep lockup with no hard and fast date. btw the company never kept that little tidbit secret for years. however, its kind of like a parent telling a child how its gonna be. especially after the formatech fiasco. ok, everybody out of the pool!